Clinical studies regarding HSP60, antibody anti-HSP60 and risk factors for atherosclerosis are controversial, demonstrating the relevance of further studies especially focused on elderly with risk factors for CVD developments (Terry et al., 2004; Ellins et al., 2008). The gene discussed is HSPD1; the disease is atherosclerosis.